$359.92 +1.00 (%) Regeneron Pharmaceuticals Inc - NASDAQ

Sep. 22, 2014 | 04:00 PM

Partner Headlines

  1. UPDATE: Morgan Stanley Reiterates On Regeneron Pharmaceuticals Inc Following DME Doc Event

    Benzinga | Sep. 18, 2014 | 10:51AM EST
  2. Stocks Erase Modest Gains; Netflix Gaps Below 50-Day Line

    IBD | Sep. 16, 2014 | 12:12PM EST
  3. Deutsche Bank Is Bullish On Gilead Sciences, Inc. And Other Biotech Stocks

    Benzinga | Sep. 16, 2014 | 08:19AM EST
  4. Stocks Show Modest Losses; Biotechs Pressured Again

    IBD | Sep. 11, 2014 | 14:46PM EST
  5. Stocks Hold Modest Gains; FleetCor Reverses Higher

    IBD | Sep. 10, 2014 | 14:53PM EST
  6. Stocks Turn Higher After Soft Start; U.S. Silica Jumps

    IBD | Sep. 10, 2014 | 13:25PM EST
  7. Novartis Drug Is Heartening

    IBD | Sep. 2, 2014 | 18:39PM EST
  8. Novartis, Regeneron Cardio Results Pump Up Wall St.

    IBD | Sep. 2, 2014 | 18:04PM EST
  9. Novartis, Regeneron Hit New Highs On Cardio Drugs

    IBD | Sep. 2, 2014 | 11:19AM EST
  10. Thin Gains Quickly Turn Mixed; Regeneron, Staples Surge Ahead

    IBD | Sep. 2, 2014 | 10:43AM EST
  11. UPDATE: Morgan Stanley Reiterates On Regeneron Pharmaceuticals Ahead Of Conference Call

    Benzinga | Sep. 2, 2014 | 09:36AM EST
  12. Nasdaq, S&P 500 Rise In Lackluster Session; Tesla Gains

    IBD | Aug. 29, 2014 | 15:12PM EST
  13. Nasdaq Leads Quiet, Pre-Holiday Session; NXP Breaks Out

    IBD | Aug. 29, 2014 | 13:35PM EST
  14. Amgen edges up on trial results

    IBD | Aug. 28, 2014 | 18:42PM EST
  15. Stocks Indexes Fall Modestly, Shaking Off Ukraine Unrest

    IBD | Aug. 28, 2014 | 15:03PM EST
  16. Economic Data Fuel Another All-Time High For S&P 500

    IBD | Aug. 26, 2014 | 15:36PM EST
  17. Qihoo, Regeneron Among 5 Stocks With Top Fundamentals

    IBD | Aug. 21, 2014 | 13:25PM EST
  18. Jazz, Celgene Lead Top 4 Drugmaker Profit Margins

    IBD | Aug. 18, 2014 | 13:46PM EST
  19. Drugmaker Q2 Profits Robust

    IBD | Aug. 5, 2014 | 18:51PM EST
  20. 4 Top-Rated Drugmakers Beat Q2 Earnings Estimates

    IBD | Aug. 5, 2014 | 18:30PM EST
  21. Deutsche Bank Raises Regeneron's Price Target To $425

    Benzinga | Aug. 5, 2014 | 15:30PM EST
  22. UPDATE: Regeneron Posts Upbeat Q2 Results

    Benzinga | Aug. 5, 2014 | 07:03AM EST
  23. Earnings Scheduled For August 5, 2014

    Benzinga | Aug. 5, 2014 | 05:34AM EST
  24. Len Schleifer's Science Focus Pays Off At Regeneron

    IBD | Jul. 31, 2014 | 14:12PM EST
  25. Stocks End Mixed; Akamai Falls, Yelp Rises After Hours

    IBD | Jul. 30, 2014 | 17:00PM EST
  26. Amgen Restructuring Plan, Q2 Earnings Send Stock Up

    IBD | Jul. 30, 2014 | 11:20AM EST
  27. Stocks Thrash Out A Mixed Open; Buffalo Wild Wings Crumples

    IBD | Jul. 30, 2014 | 10:31AM EST
  28. Celgene, Alexion Beat Estimates, But Biotechs Fall

    IBD | Jul. 24, 2014 | 17:07PM EST
  29. Stocks Recover Impressively; Gap Slumps In After Hours

    IBD | Jul. 10, 2014 | 17:22PM EST
  30. Regeneron's Dupilumab Drug Headed For Phase Three Tests

    IBD | Jul. 10, 2014 | 13:46PM EST
  31. Market Slides On European Bank Worries; Gold Stocks Rise

    IBD | Jul. 10, 2014 | 12:07PM EST
  32. UPDATE: Morgan Stanley Reiterates On Regeneron Pharmaceuticals Following Good Results Of Drug Study

    Benzinga | Jul. 10, 2014 | 10:03AM EST
  33. Benzinga's Top #PreMarket Gainers

    Benzinga | Jul. 10, 2014 | 08:09AM EST
  34. UPDATE: Regeneron, Sanofi Offer Positive Results from Phase 2b Study of Dupilum, All Doses Met Primary Endpoint

    Benzinga | Jul. 9, 2014 | 17:02PM EST
  35. Citi Sees Plenty Of Q2 Earnings Beats Ahead In Biotech Sector

    Benzinga | Jul. 3, 2014 | 12:26PM EST
  36. Pharmas Soar To New Highs

    IBD | Jul. 1, 2014 | 18:45PM EST
  37. Salix, Akorn, Regeneron Lead Drug Stock Rally

    IBD | Jul. 1, 2014 | 17:19PM EST
  38. Stocks Rise In Strong Turnover; Netflix Soars On Upgrade

    IBD | Jul. 1, 2014 | 13:22PM EST
  39. Regeneron Rises As Sanofi Raises Stake In Biotech

    IBD | Jul. 1, 2014 | 13:12PM EST
  40. Bristol-Myers, Pfizer, Regeneron Drugs Get EU Nods

    IBD | Jun. 27, 2014 | 11:50AM EST
  41. US Stock Futures Drop Ahead Of Consumer Sentiment Report

    Benzinga | Jun. 27, 2014 | 07:41AM EST
  42. EYLEA Injection Recommended For Approval Regarding Treatment Of Visual Impairment Due To Diabetic Macular Edema In The European Union

    Benzinga | Jun. 27, 2014 | 07:18AM EST
  43. Auxilium Acquiring QLT For New Products, Low Taxes

    IBD | Jun. 26, 2014 | 12:09PM EST
  44. Major Indexes Narrowly Lower As Actavis Rallies

    IBD | Jun. 23, 2014 | 13:29PM EST
  45. Regeneron Shares Fall Following BMO's Note Of Roche Preference

    Benzinga | Jun. 20, 2014 | 12:14PM EST
  46. US Stock Futures Edge Higher Ahead Of Jobless Claims, Retail Sales Data

    Benzinga | Jun. 12, 2014 | 07:28AM EST
  47. US Stock Futures Tumble; World Bank Lowers Global Growth Outlook

    Benzinga | Jun. 11, 2014 | 07:31AM EST
  48. Valeant EPS Tops, Sales Miss

    IBD | May. 8, 2014 | 18:54PM EST
  49. Valeant Reports Mixed Q1 Amid Drug Earnings Bonanza

    IBD | May. 8, 2014 | 18:35PM EST
  50. Valeant Q1 Mixed, But Strong 2014 Guidance Affirmed

    IBD | May. 8, 2014 | 11:13AM EST
Trading Center